ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
This article has 21 authors:Reviewed by ScreenIT
-
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
This article has 30 authors:Reviewed by ScreenIT
-
Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains
This article has 3 authors:Reviewed by ScreenIT
-
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters
This article has 35 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
This article has 33 authors:Reviewed by ScreenIT
-
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
This article has 15 authors:Reviewed by ScreenIT
-
COVID-19 Vaccination and Estimated Public Health Impact in California
This article has 7 authors:Reviewed by ScreenIT
-
Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease
This article has 20 authors:Reviewed by ScreenIT
-
Increasing viral transmission paradoxically reduces progression rates to severe COVID-19 during endemic transition
This article has 7 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
This article has 38 authors:Reviewed by ScreenIT